AIFF MEXC RealStocks
Own real AIFF shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-17 18:59:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Firefly Neuroscience, Inc. (AIFF) operates in the SERVICES-PREPACKAGED SOFTWARE sector and is listed on NASDAQ. The stock is currently priced at $0.91, with a market capitalization of $14.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.62 to $3.15. This page covers its latest market performance, valuation, price trends and company information.
$14.73M | |
$0.91 | |
$1.01 | |
$0.89 | |
$0.89 | |
121.10K | |
2.70M | |
-- | |
$3.15 | |
$0.62 | |
-- | |
-- |
Firefly Neuroscience, Inc. (AIFF) is currently trading at $0.91 as of 2026-11-17 18:54:00, up 2.18% ($0.02) from the previous close of $0.89
During today's regular trading session, AIFF has traded between $0.89 and $1.01, with a trading volume of 121.10K shares. The current price is near the lower end of today's range.
Over the past seven days, Firefly Neuroscience, Inc. (AIFF) moved from $0.91 to $0.91, representing a gain of 0.31% ($0.00).
The stock traded between $0.85 and $1.05 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 65.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 11.7%
AIFF is currently trading at $0.91, placing it 11.7% of the way from its 52-week low of $0.62 to its 52-week high of $3.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
| Industry | SERVICES-PREPACKAGED SOFTWARE |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Firefly Neuroscience, Inc. (AIFF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AIFF, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between AIFF shares and USD.
AIFF Shares to USD
1.00 AIFF shares = 0.913 USD
Calculations are estimates based on the latest available price and are for reference only.